Operating Cash Flow
ResMed Operating Cash Flow increased by 63.1% to $554.13M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 4.2%, from $578.66M to $554.13M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 24.2% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
Detailed definition
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Peer comparison
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operatingHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $226.53M | -$65.66M | $219.88M | $117.44M | $79.49M | $44.66M | $128.64M | $282.57M | $237.44M | $286.28M | $272.83M | $402.03M | $440.11M | $325.54M | $308.62M | $578.66M | $538.77M | $457.32M | $339.75M | $554.13M |
| QoQ Change | — | -129.0% | +434.9% | -46.6% | -32.3% | -43.8% | +188.0% | +119.7% | -16.0% | +20.6% | -4.7% | +47.4% | +9.5% | -26.0% | -5.2% | +87.5% | -6.9% | -15.1% | -25.7% | +63.1% |
| YoY Change | — | — | — | — | -64.9% | +168.0% | -41.5% | +140.6% | +198.7% | +541.0% | +112.1% | +42.3% | +85.4% | +13.7% | +13.1% | +43.9% | +22.4% | +40.5% | +10.1% | -4.2% |
Operating Cash Flow at Other Companies
Frequently Asked Questions
- What is ResMed's operating cash flow?
- ResMed (RMD) reported operating cash flow of $554.13M in Q1 2026.
- How has ResMed's operating cash flow changed year-over-year?
- ResMed's operating cash flow decreased by 4.2% year-over-year, from $578.66M to $554.13M.
- What is the long-term trend for ResMed's operating cash flow?
- Over 4 years (2021 to 2025), ResMed's operating cash flow has grown at a 24.2% compound annual growth rate (CAGR), from $736.72M to $1.75B.
- What does operating cash flow mean?
- The amount of cash a company generates from its regular business activities.